Showing results (61-70 of 5,288) with videos related to
Sort By:
Pageof 529
Journal of Hematotherapy & Stem Cell Research|September 12, 2000
Activity of acetyl-Ser-Asp-Lys-Pro (AcSDKP) on human hematopoietic progenitor cells in short-term and long-term bone marrow culturesJ D Jackson, E Ozerol, Y Yan, et al.Nature|April 17, 1980
Role of NK cells in tumour growth and metastasis in beige miceJ E Talmadge, K M Meyers, D J Prieur, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosisH Fukui, C W Reynolds, B Lenz, et al.Experimental Hematology|February 1, 1992
Regulation of colony-stimulating activity production from bone marrow stromal cells by the hematoregulatory peptide, HP-5A G King, J E Talmadge, A M Badger, et al.Immunopharmacology|February 1, 1984
The effect of experimental conditions on the assessment of T cell immunomodulation by biological response modifiers (thymosin fraction five)J E Talmadge, K L Benedict, K A Uithoven, et al.Cancer Research|April 1, 1985
Development and progression of karyotypic variability in melanoma K1735 following X-irradiationS R Wolman, L E McMorrow, I J Fidler, et al.Acta Haematologica|April 15, 1999
Adenovirus p53 purging for human breast cancer stem cell productsM Hirai, L S Kelsey, D C Maneval, et al.Cancer Research|May 15, 1987
Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in miceJ E Talmadge, H R Tribble, R W Pennington, et al.Clinical & Experimental Metastasis|January 29, 2000
N-linked oligosaccharides and metastatic propensity in in vivo selected mouse mammary adenocarcinoma cellsP J Seberger, E M Scholar, L Kelsey, et al.Bone Marrow Transplantation|June 1, 1997
GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expressionT Watanabe, B Dave, D G Heimann, et al.Pageof 529